These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8816618

  • 1. The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized study.
    van der Meer M, Hompes PG, Scheele F, Schoute E, Popp-Snijders C, Schoemaker J.
    Fertil Steril; 1996 Oct; 66(4):571-6. PubMed ID: 8816618
    [Abstract] [Full Text] [Related]

  • 2. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
    Anderson RA, Groome NP, Baird DT.
    Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
    [Abstract] [Full Text] [Related]

  • 3. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC, Hop WC, de Jong FH, van Dessel TJ, Fauser BC.
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [Abstract] [Full Text] [Related]

  • 4. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
    Fauser BC, Donderwinkel P, Schoot DC.
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
    [Abstract] [Full Text] [Related]

  • 5. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S, Schipper I, de Jong FH, Themmen AP, Visser JA, Laven JS.
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [Abstract] [Full Text] [Related]

  • 6. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome.
    van der Meer M, Hompes PG, Scheele F, Schoute E, Veersema S, Schoemaker J.
    Hum Reprod; 1994 Sep; 9(9):1612-7. PubMed ID: 7836509
    [Abstract] [Full Text] [Related]

  • 7. The relationship between follicle-stimulating hormone dose and level and its relevance for ovulation induction with adjuvant gonadotropin-releasing hormone-agonist treatment.
    Scheele F, Hompes PG, van der Meer M, Schoute E, Schoemaker J.
    Fertil Steril; 1993 Oct; 60(4):620-5. PubMed ID: 8405514
    [Abstract] [Full Text] [Related]

  • 8. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM, Muttukrishna S, Groome NP, Matthews DR, Ledger WL.
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [Abstract] [Full Text] [Related]

  • 9. Immunoreactive inhibin levels during ovarian stimulation may predict granulosa cell maturity.
    Buckler HM, Robertson WR, Sun JG, Morris ID.
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):552-7. PubMed ID: 1286525
    [Abstract] [Full Text] [Related]

  • 10. The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome.
    Scheele F, Hompes PG, van der Meer M, Schoute E, Schoemaker J.
    Hum Reprod; 1993 May; 8(5):699-704. PubMed ID: 8314962
    [Abstract] [Full Text] [Related]

  • 11. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, Hall JE.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [Abstract] [Full Text] [Related]

  • 12. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A, Sauter L, Edimiris P, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [Abstract] [Full Text] [Related]

  • 13. Management of women with polycystic ovary syndrome who experienced premature luteinization during clomiphene citrate treatment.
    Lidor AL, Goldenberg M, Cohen SB, Seidman DS, Mashiach S, Rabinovici J.
    Fertil Steril; 2000 Oct; 74(4):749-52. PubMed ID: 11020518
    [Abstract] [Full Text] [Related]

  • 14. Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen.
    Schoot DC, Hop WC, Pache TD, de Jong FH, Fauser BC.
    Acta Endocrinol (Copenh); 1993 Aug; 129(2):126-9. PubMed ID: 8372596
    [Abstract] [Full Text] [Related]

  • 15. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome.
    De Leo V, la Marca A, Ditto A, Morgante G, Cianci A.
    Fertil Steril; 1999 Aug; 72(2):282-5. PubMed ID: 10438996
    [Abstract] [Full Text] [Related]

  • 16. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
    van Santbrink EJ, Fauser BC.
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
    [Abstract] [Full Text] [Related]

  • 17. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D, Vandekerckhove P, Hughes E, Arnot M, Lilford R.
    Cochrane Database Syst Rev; 2000 Nov; (4):CD000410. PubMed ID: 11034687
    [Abstract] [Full Text] [Related]

  • 18. Exploring the recovery phase after treatment with a gonadotrophin-releasing hormone-agonist for ovulation induction in polycystic ovary syndrome: three pilot trials.
    Scheele F, van der Meer M, Lambalk CB, Schoute E, Schoemaker J, Hompes PG.
    Eur J Obstet Gynecol Reprod Biol; 1995 Oct; 62(2):221-4. PubMed ID: 8582500
    [Abstract] [Full Text] [Related]

  • 19. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
    Bregieiro LO, de Moura MD, Ferriani RA, Bailão LA, de Sá MF.
    Int J Fertil Menopausal Stud; 1993 Oct; 38(3):152-9. PubMed ID: 8348163
    [Abstract] [Full Text] [Related]

  • 20. The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries.
    Elting MW, Kwee J, Schats R, Rekers-Mombarg LT, Schoemaker J.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1589-95. PubMed ID: 11297588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.